Source: Annual Congress 2002 - Lung cancer: treatment



Rating:

Share or cite this content

Citations should be made in the following way:
R. Milroy, T. S. Ismail, J. McPhelim, S. Davidson, R. Bradley, R. Jones (Glasgow, United Kingdom). Chemotherapy for lung cancer in Scotland: a national survey. Eur Respir J 2002; 20: Suppl. 38, 2937

Member's Comments

No comment yet.

Related content which might interest you: Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001 Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 The influence of the UK national lung cancer campaign on fast-track referrals to secondary care Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Assessing the local impact of a national lung cancer awareness campaign Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 A feasibility study: Home-telemonitoring for rural lung cancer patients Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Therapeutic management of non-small cell lung cancers in Tunisia Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Lung cancer treatment strategies in district general hospital Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 Lung cancer treatment strategies in a district general hospital Source: Eur Respir J 2006; 28: Suppl. 50, 750s Year: 2006 Impact of a lung cancer screening programme on a London hospital service Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Epidemiology of lung cancer in Constantza county Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 Delay in diagnosis and management of lung cancer in developing countries Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 The feasibility of a lung cancer screening program in rural Ireland Source: Eur Respir J 2006; 28: Suppl. 50, 80s Year: 2006